Ortho-McNeil Pharmaceutical
Ortho-McNeil Pharmaceutical[edit]
Ortho-McNeil Pharmaceutical was a pharmaceutical company that operated as a subsidiary of Johnson & Johnson. It was known for developing and marketing a range of prescription medications, particularly in the fields of neurology, psychiatry, and women's health.
History[edit]
Ortho-McNeil Pharmaceutical was formed through the merger of two companies: Ortho Pharmaceutical and McNeil Pharmaceutical. Ortho Pharmaceutical was originally founded in 1931 and was known for its contributions to the field of contraception and women's health. McNeil Pharmaceutical, on the other hand, was established in 1879 and became well-known for its development of Tylenol, a widely used analgesic.
The merger of these two companies allowed Ortho-McNeil to leverage the strengths of both entities, expanding its product offerings and research capabilities. The company became a significant player in the pharmaceutical industry, particularly in the United States.
Products[edit]
Ortho-McNeil Pharmaceutical developed and marketed a variety of prescription medications. Some of the notable products included:
- Topamax (topiramate) - An anticonvulsant used to treat epilepsy and prevent migraine headaches.
- Levaquin (levofloxacin) - An antibiotic used to treat a variety of bacterial infections.
- Ortho Tri-Cyclen - An oral contraceptive used for birth control and to treat acne.
Research and Development[edit]
The company invested heavily in research and development to bring new and innovative treatments to market. Ortho-McNeil's R&D efforts were focused on areas such as central nervous system disorders, infectious diseases, and women's health.
Merger and Transition[edit]
In 2008, Ortho-McNeil Pharmaceutical was merged with Janssen Pharmaceutica, another subsidiary of Johnson & Johnson, to form Ortho-McNeil-Janssen Pharmaceuticals. This merger was part of a strategic move to consolidate Johnson & Johnson's pharmaceutical operations and streamline its product offerings.
Related pages[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian